Clinical Trials Logo

Spinal Cord Injuries clinical trials

View clinical trials related to Spinal Cord Injuries.

Filter by:

NCT ID: NCT04400747 Completed - Spinal Cord Injury Clinical Trials

Oral Colecalciferol Treatment in Spinal Cord Lesion

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Low vitamin D is frequently seen in patients with spinal cord injury (SCI) in acute and chronic periods. Among its causes are insufficient sun exposure, limited oral intake, obesity, the effect of the drugs used on the absorption of vitamin D, kidney and liver diseases. If we consider patients with spinal cord injuries in Turkey, it is difficult to get involved in the society, low exposure to the sun, lack of necessary health controls and immobility brings extra risk factors for the low vitamin D compared to the general population. Despite Turkey Endocrinology and Metabolism Endocrine Society and the International Endocrine Association clinical practice guidelines do not provide specific recommendations about vitamin D, for individuals with spinal cord injuries. Individuals with SCI are at high risk for low vitamin D. Vitamin D levels need to be checked and replaced. Vitamin D doses, application methods and dose intervals used in Physical Therapy and Rehabilitation clinics are different. The aim of our study is to perform the necessary vitamin D replacement for individuals with SCI who have vitamin D deficiency in different dose intervals and to compare the effects of muscle strength, muscle thickness and functional independence with the control group.

NCT ID: NCT04393922 Recruiting - Clinical trials for Spinal Cord Injuries

Spasticity After Spinal Cord Injury

Start date: May 13, 2020
Phase: N/A
Study type: Interventional

Very often, people who have a SCI have difficulty doing things with their arms or hands as a result of muscle stiffness , or spasticity. Spastacity can cause problems performing even the simplest of everyday tasks. This research will help us understand how the body recovers and changes neurologically after SCI.

NCT ID: NCT04390087 Completed - Clinical trials for Spinal Cord Injuries

Effect of Upper-body Rowing on Cardiometabolic Risk in Spinal Cord Injured Wheelchair Users

Start date: January 11, 2021
Phase: N/A
Study type: Interventional

This randomized controlled trial will determine the effects of 12-weeks of wheelchair user-modified upper-body rowing on both traditional cardiometabolic risk factors in SCI manual wheelchair users.

NCT ID: NCT04386174 Recruiting - Spinal Cord Injury Clinical Trials

Brain Activity in People With Chronic Neuropathic Pain and Spinal Cord Injury

Start date: August 1, 2020
Phase: Early Phase 1
Study type: Interventional

The purpose of this research study is to learn more about how patterns of brain activity change during different thinking tasks and how these changes relate to the intensity and unpleasantness of the neuropathic pain that people with SCI experience.

NCT ID: NCT04384172 Completed - Clinical trials for Spinal Cord Injuries

Effect of Peripheral Neuromodulation on Vaginal Blood Flow

Start date: November 11, 2020
Phase: N/A
Study type: Interventional

The researchers want to see if nerve stimulation interventions cause a change in vaginal blood flow. The effect of this intervention will be compared between women who have neurogenic (spinal cord injury) or non-neurogenic dysfunction and healthy women.

NCT ID: NCT04383873 Completed - Clinical trials for Spinal Cord Injury Cervical

Effectiveness Analysis of Armeo Spring Device as a Rehabilitation Treatment in Spinal Cord Injured Patients

Start date: June 18, 2016
Phase: N/A
Study type: Interventional

Loss of motor function is a consequence after a spinal cord injury (SCI). The incidence of SCI varies greatly from 12.1 to 57.8 cases per million depending on the country. More than 50% of people with SCI have impaired upper limb (UL) function, experiencing limitations in performing functional tasks. In this context, one of the rehabilitation objectives is to achieve the maximum level of independence in the patient in the performance of activities of daily living (ADL). Within the clinical setting, the main motivation in the use of robotic devices and/or exoskeletons for a rehabilitation purpose focuses on the fact that these help therapists in administering repetitive manual therapies to patients during exercises. There is evidence that the amount of therapy patients receive is insufficient. Without creating additional time demands on clinicians, robotic devices can perform the repetitive mechanical aspects of therapy, increasing the amount of therapy that patients receive. However, the current evidence in stroke patients suggests that the improvements observed are due to the intensity of the therapy, regardless of whether the administration of rehabilitation is due to robotic devices and/or traditional means. The main objective of this study is to analyze the effectiveness of the commercial Armeo® Spring system (Hocoma AG, Switzerland) and a Virtual Reality application to repeatedly work the ADL from drinking from a glass, in people with cervical SCI. The ADL of drinking has been chosen, as a representative activity of those related to food, which requires control, strength and coordination of the UL. The study is carried out at the Hospital Nacional de Parapléjicos with the collaboration of Occupational Therapy Unit, the Rehabilitation Department, and the Biomechanics and Technical Aids Unit. This effectiveness is measured in terms of functional improvements and in the quality of the UL movements performed.

NCT ID: NCT04379011 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury

Start date: February 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Spinal cord injury (SCI) is associated with severe neuropathic pain that is often refractory to all pharmacological intervention. Preliminary data suggest brivarecetum is a mechanism-based pharmacological intervention for neuropathic pain in SCI. This randomized, placebo-controlled pilot clinical trial will assess feasibility of a 3-month treatment course with brivarecetum.

NCT ID: NCT04378218 Completed - Paraplegia, Spinal Clinical Trials

Cardiovascular Effects of High Intensity Interval Training in Individuals With Paraplegia

HIIT
Start date: December 12, 2019
Phase: N/A
Study type: Interventional

The study seeks to determine whether high intensity interval training has an effect on cardiovascular parameters in wheelchair users with paraplegia.

NCT ID: NCT04373512 Recruiting - Clinical trials for Spinal Cord Injuries

Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury

Start date: May 20, 2020
Phase: Phase 2
Study type: Interventional

The objectives of the proposed research among this population are: 1) to define clinically meaningful change (i.e. differentiating states of health and illness) with respect to urinary symptoms, urine inflammation, cultivable bacteria, and the urine ecosystem; and 2) to determine the optimal intravesical Lactobacillus RhamnosusGG (LGG®) dose to be used to reduce urinary symptoms in a future clinical trial.

NCT ID: NCT04372134 Completed - Spinal Cord Injury Clinical Trials

The Effect of rTMS in Patients With Spinal Cord Injury (rTMS:Repetetive Transcranial Magnetic Stimulation)

rTMS:
Start date: October 1, 2015
Phase: N/A
Study type: Interventional

It is postulated that high frequency repetitive transcranial magnetic stimulation (rTMS) can decrease the corticospinal inhibition and enhance the motor recovery. This study is aimed to investigate the effect of high frequency rTMS on lower extremity motor recovery and gait parameters in patients with chronic motor incomplete traumatic spinal cord injury (SCI).